Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Cipla Gets CGT Nod For US Migranal Rival
FDA Approval With CGT Designation Comes With 180-Day Exclusivity
Jun 08 2020
•
By
Akriti Seth
Cipla is ready to ship its newly-approved nasal spray immediately • Source: Shutterstock
More from Products
More from Generics Bulletin